What does CUSIP 829399104 represent in this 13F holders report?

CUSIP 829399104 is the security identifier for SIOX - SIO GENE THERAPIES INC - COMMON used to aggregate holder disclosures.

How many institutions held SIOX - SIO GENE THERAPIES INC - COMMON in Q4 2020?

52 institutional investors reported SIOX - SIO GENE THERAPIES INC - COMMON for Q4 2020. Use the holders table for investor-level position and value details.

SIO GENE THERAPIES INC - COMMON (SIOX)

CUSIP: 829399104

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class: Equity / COMMON
Total 13F shares: 14,252,705
Share change: +13,647,205
Total reported value: $39,625,394
Put/Call ratio: 140%
Price per share: $2.78
Number of holders: 52
Value change: +$37,942,387
Number of buys: 47

Quarterly Holders Quick Answers

What is CUSIP 829399104?
CUSIP 829399104 identifies SIOX - SIO GENE THERAPIES INC - COMMON in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2021

Recent filing periods for CUSIP 829399104:

Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021

Institutional Holders of SIO GENE THERAPIES INC - COMMON (SIOX) as of Q4 2020

As of 31 Dec 2020, SIO GENE THERAPIES INC - COMMON (SIOX) was held by 52 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 14,252,705 shares. The largest 10 holders included Consonance Capital Management LP, Rubric Capital Management LP, Opaleye Management Inc., Charles Winkler, VANGUARD GROUP INC, Sio Capital Management, LLC, GSA CAPITAL PARTNERS LLP, MORGAN STANLEY, Sassicaia Capital Advisers LLC, and Verition Fund Management LLC. This page lists 52 institutional shareholders reporting positions in this security for the Q4 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.